133 related articles for article (PubMed ID: 32265418)
1. Decrease in the Risk of Posttransplant Hepatocellular Carcinoma Recurrence After the Conversion to Prestorage Leukoreduction for Transfused Red Blood Cells.
Kwon JH; Han S; Jang JS; Lee KW; Ahn JH; Kim K; Jeon S; Gwak MS; Ko JS; Kim GS; Joh JW; Cho D
Transplantation; 2021 Mar; 105(3):577-585. PubMed ID: 32265418
[TBL] [Abstract][Full Text] [Related]
2. Blood Salvage and Autotransfusion With Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence After Liver Transplantation for Advanced Hepatocellular Carcinoma.
Kwon JH; Han S; Kim D; Kuk JH; Cho H; Kim S; Yang JD; Kim C; Kim JM; Choi GS; Joh JW; Ko JS; Gwak MS; Kim G
Ann Surg; 2022 Dec; 276(6):e842-e850. PubMed ID: 33914466
[TBL] [Abstract][Full Text] [Related]
3. Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantation.
Han S; Lee S; Yang JD; Leise MD; Ahn JH; Kim S; Jung K; Gwak MS; Kim GS; Ko JS
Liver Transpl; 2018 Jan; 24(1):44-55. PubMed ID: 29024412
[TBL] [Abstract][Full Text] [Related]
4. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
[TBL] [Abstract][Full Text] [Related]
5. Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors.
Han S; Yang JD; Sinn DH; Kim JM; Choi GS; Jung G; Ahn JH; Kim S; Ko JS; Gwak MS; Kwon CHD; Leise MD; Gwak GY; Heimbach JK; Kim GS
Ann Surg; 2018 Dec; 268(6):1043-1050. PubMed ID: 28628564
[TBL] [Abstract][Full Text] [Related]
6. Red Blood Cells' Prestorage Leukoreduction and Reduced Risk of Posttransplant Hepatocellular Cancer Recurrence: Another Piece of the Tumor-immune System Puzzle?
Lerut JP; Lai Q
Transplantation; 2021 Mar; 105(3):476-477. PubMed ID: 32265419
[No Abstract] [Full Text] [Related]
7. Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation.
Han S; Kwon JH; Jung SH; Seo JY; Jo YJ; Jang JS; Yeon SM; Jung SH; Ko JS; Gwak MS; Cho D; Son HJ; Kim GS
Ann Surg; 2018 Feb; 267(2):346-351. PubMed ID: 27805962
[TBL] [Abstract][Full Text] [Related]
8. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
9. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
11. Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.
Rajesh K; Harsh S; Amarjit K
Ann Med Health Sci Res; 2015; 5(3):185-8. PubMed ID: 26097760
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Risk Factor of Hepatocellular Carcinoma Recurrence After Liver Transplant: Results From a Single Clinic.
Bolkvadze R; Kashibadze K; Nakashidze M; Mikeladze L; Beridze D; Beridze S
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):256-262. PubMed ID: 38385408
[TBL] [Abstract][Full Text] [Related]
13. Higher Bilirubin Levels of Healthy Living Liver Donors Are Associated With Lower Posttransplant Hepatocellular Carcinoma Recurrence.
Han S; Yang JD; Sinn DH; Ko JS; Kim JM; Shin JC; Son HJ; Gwak MS; Joh JW; Kim GS
Transplantation; 2016 Sep; 100(9):1933-8. PubMed ID: 27362316
[TBL] [Abstract][Full Text] [Related]
14. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation.
Goldaracena N; Mehta N; Scalera I; Sposito C; Atenafu EG; Yao FY; Muiesan P; Mazzaferro V; Sapisochin G
HPB (Oxford); 2019 Jun; 21(6):731-738. PubMed ID: 30391218
[TBL] [Abstract][Full Text] [Related]
15. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
Kim SH; Lee EC; Na BG; Park SJ
Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
17. Transfusion-associated adverse reactions (TAARs) and cytokine accumulations in the stored blood components: the impact of prestorage versus poststorage leukoreduction.
Chang CC; Lee TC; Su MJ; Lin HC; Cheng FY; Chen YT; Yen TH; Chu FY
Oncotarget; 2018 Jan; 9(4):4385-4394. PubMed ID: 29435110
[TBL] [Abstract][Full Text] [Related]
18. Different prognostic factors and strategies for early and late recurrence after adult living donor liver transplantation for hepatocellular carcinoma.
Hong SK; Lee KW; Yoon KC; Kim HS; Ahn SW; Kim H; Lee JM; Cho JH; Yi NJ; Suh KS
Clin Transplant; 2019 Oct; 33(10):e13703. PubMed ID: 31464006
[TBL] [Abstract][Full Text] [Related]
19. Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction.
Biffl WL; Moore EE; Offner PJ; Ciesla DJ; Gonzalez RJ; Silliman CC
J Trauma; 2001 Mar; 50(3):426-31; discussion 432. PubMed ID: 11265021
[TBL] [Abstract][Full Text] [Related]
20. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL
Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]